NCT03419130 2018-12-07
Radiation Therapy and Pembrolizumab in Treating Patients With Localized Urothelial Bladder Cancer
University of California, San Francisco
Phase 2 Withdrawn
Clinical Trials
1 trialsWithdrawn × Infiltrating Bladder Urothelial Carcinoma × Radiation Dose Hypofractionation × Clear all